<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03458468</url>
  </required_header>
  <id_info>
    <org_study_id>SSC-Latarjet-001</org_study_id>
    <nct_id>NCT03458468</nct_id>
  </id_info>
  <brief_title>Tranexamic Acid for the Latarjet Procedure.</brief_title>
  <official_title>A Randomised, Prospective Evaluation on the Effectiveness of Tranexamic Acid in Reducing Postoperative Swelling and Haematoma Formation After the Latarjet Procedure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sports Surgery Clinic, Santry, Dublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sports Surgery Clinic, Santry, Dublin</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose a double-blinded randomized study evaluating the effectiveness of
      tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet
      procedure.

      The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via
      intra-articular injection at the time of surgery in patients undergoing the Latarjet
      procedure for shoulder instability.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">March 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double-blinded randomized</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Hematoma Formation</measure>
    <time_frame>Postoperative day-1</time_frame>
    <description>Patients hematoma formation will be evaluated using the Pauzenberger criteria (Grade 1-4)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>Postoperative day-1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Drain output</measure>
    <time_frame>Postoperative day-1</time_frame>
    <description>The total drain output of blood post-operatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>Postoperative day-1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound complications</measure>
    <time_frame>Postoperative week-2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total complications</measure>
    <time_frame>Postoperative month-4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haematoma Formation</measure>
    <time_frame>Postoperative week-2</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Anterior Shoulder Instability</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tranexamic Acid 1g IV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid</intervention_name>
    <description>1g Tranexamic acid prior to skin incision</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Equivalent volume of saline prior to skin incision</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢ Anterior shoulder instability, warranting the Latarjet procedure

        Exclusion Criteria:

          -  Patients with known risk factors for hyper-coagulable state

          -  Patients under 16

          -  Patients unable to give consent to partake in the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hannan Mullett, FRCSI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sports Surgery Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sports Surgery Clinic</name>
      <address>
        <city>Santry</city>
        <state>Dublin</state>
        <zip>9</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <reference>
    <citation>Gillespie R, Shishani Y, Joseph S, Streit JJ, Gobezie R. Neer Award 2015: A randomized, prospective evaluation on the effectiveness of tranexamic acid in reducing blood loss after total shoulder arthroplasty. J Shoulder Elbow Surg. 2015 Nov;24(11):1679-84. doi: 10.1016/j.jse.2015.07.029.</citation>
    <PMID>26480877</PMID>
  </reference>
  <reference>
    <citation>Pauzenberger L, Domej MA, Heuberer PR, Hexel M, Grieb A, Laky B, Blasl J, Anderl W. The effect of intravenous tranexamic acid on blood loss and early post-operative pain in total shoulder arthroplasty. Bone Joint J. 2017 Aug;99-B(8):1073-1079. doi: 10.1302/0301-620X.99B8.BJJ-2016-1205.R1.</citation>
    <PMID>28768785</PMID>
  </reference>
  <reference>
    <citation>Vara AD, Koueiter DM, Pinkas DE, Gowda A, Wiater BP, Wiater JM. Intravenous tranexamic acid reduces total blood loss in reverse total shoulder arthroplasty: a prospective, double-blinded, randomized, controlled trial. J Shoulder Elbow Surg. 2017 Aug;26(8):1383-1389. doi: 10.1016/j.jse.2017.01.005. Epub 2017 Feb 3.</citation>
    <PMID>28162887</PMID>
  </reference>
  <reference>
    <citation>Kirsch JM, Bedi A, Horner N, Wiater JM, Pauzenberger L, Koueiter DM, Miller BS, Bhandari M, Khan M. Tranexamic Acid in Shoulder Arthroplasty: A Systematic Review and Meta-Analysis. JBJS Rev. 2017 Sep;5(9):e3. doi: 10.2106/JBJS.RVW.17.00021. Review.</citation>
    <PMID>28902659</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>February 19, 2018</study_first_submitted>
  <study_first_submitted_qc>March 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>July 26, 2019</last_update_submitted>
  <last_update_submitted_qc>July 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tranexamic acid</keyword>
  <keyword>anterior shoulder instability</keyword>
  <keyword>latarjet</keyword>
  <keyword>hematoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

